Jump to content

The Angiogenesis Foundation

From Wikipedia, the free encyclopedia
The Angiogenesis Foundation
Company typeNon-profit
Founded1994 in Cambridge, MA
FounderWilliam W. Li, MD and Vincent W. Li, MD (co-founders)
HeadquartersCambridge, MA, U.S.
Revenue1,772,286 United States dollar (2017) Edit this on Wikidata
Websiteangio.org

The Angiogenesis Foundation, is a United States 501(c)(3) nonprofit organization established in 1994 for the study of angiogenesis. The foundation developed a therapy for canine cancer, called the Navy Protocol. This treatment works by starving the tumor of its blood supply.[1] In 2004, they helped publicly launch the first antiangiogenic therapy for cancer, bevacizumab, starting with colorectal cancer.[2]

Co-founder Dr. William Li won the 2024 Dr. Andrew von Eschenbach Award for his work in angiogenesis.[3]

References

[edit]
[edit]